Glipizide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, ChronicInterventions: Drug: Sitagliptin; Drug: Glipizide; Drug: Placebo for Sitagliptin; Drug: Placebo for GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2007 Category: Research Source Type: clinical trials

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, ChronicInterventions: Drug: Sitagliptin; Drug: Glipizide; Drug: Placebo for Sitagliptin; Drug: Placebo for GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2007 Category: Research Source Type: clinical trials

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
Conditions: Diabetes Mellitus, Type 2; End-Stage Kidney DiseaseInterventions: Drug: Sitagliptin; Drug: GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2007 Category: Research Source Type: clinical trials